IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,865,000 | -1.4% | 3,789,000 | 0.0% | 0.05% | +64.3% |
| Q4 2021 | $3,919,000 | -5.2% | 3,789,000 | 0.0% | 0.03% | -22.2% |
| Q3 2021 | $4,132,000 | -4.0% | 3,789,000 | -3.9% | 0.04% | -7.7% |
| Q2 2021 | $4,304,000 | +12.1% | 3,942,000 | +10.6% | 0.04% | -9.3% |
| Q1 2021 | $3,841,000 | -20.3% | 3,565,000 | -19.9% | 0.04% | +2.4% |
| Q4 2020 | $4,819,000 | +287.7% | 4,453,000 | +272.3% | 0.04% | +68.0% |
| Q3 2020 | $1,243,000 | -1.2% | 1,196,000 | 0.0% | 0.02% | -39.0% |
| Q2 2020 | $1,258,000 | -1.0% | 1,196,000 | 0.0% | 0.04% | -18.0% |
| Q1 2020 | $1,271,000 | -9.5% | 1,196,000 | 0.0% | 0.05% | +92.3% |
| Q4 2019 | $1,404,000 | -92.5% | 1,196,000 | -93.1% | 0.03% | -95.0% |
| Q2 2019 | $18,669,000 | +51.8% | 17,430,000 | +56.5% | 0.52% | +9.6% |
| Q1 2019 | $12,301,000 | -7.5% | 11,136,000 | -21.3% | 0.48% | -49.7% |
| Q4 2018 | $13,295,000 | – | 14,145,000 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,332,000 | 0.80% |
| DeepCurrents Investment Group LLC | 13,031,000 | $13,256,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 40,592,000 | $41,217,000 | 0.40% |
| CSS LLC/IL | 10,119,000 | $10,159,000 | 0.37% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $10,116,000 | 0.20% |
| HBK INVESTMENTS L P | 14,616,000 | $14,753,000 | 0.06% |
| Walleye Capital LLC | 2,000 | $2,040,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,054,000 | $2,092,000 | 0.05% |
| Verition Fund Management LLC | 3,789,000 | $3,865,000 | 0.05% |
| OAKTREE CAPITAL MANAGEMENT LP | 818,000 | $834,000 | 0.01% |